Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.510
+0.130 (5.46%)
At close: Apr 14, 2026, 4:00 PM EDT
2.470
-0.040 (-1.59%)
After-hours: Apr 14, 2026, 6:46 PM EDT

Organogenesis Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3236584025373521,189
Market Cap Growth
-45.48%63.45%-25.09%52.51%-70.38%23.62%
Enterprise Value
305.24746.38436.99532.39356.431,192
Last Close Price
2.515.183.204.092.699.24
PE Ratio
16.7334.53-320.00102.2522.4213.20
Forward PE
-24.6758.18136.3311.9623.39
PS Ratio
0.571.170.831.240.782.54
PB Ratio
1.012.191.531.931.334.93
P/TBV Ratio
1.082.251.601.951.345.12
P/FCF Ratio
--174.43-463.52-25.30-38.9638.66
P/OCF Ratio
-63.3543.90171.1614.1719.18
EV/Sales Ratio
0.541.320.911.230.792.55
EV/EBITDA Ratio
4.0710.4218.1414.808.8413.41
EV/EBIT Ratio
5.4116.70-340.6042.5115.9816.51
EV/FCF Ratio
--197.98-503.45-25.08-39.4338.76
Debt / Equity Ratio
0.110.110.130.360.400.49
Debt / EBITDA Ratio
1.401.403.593.323.071.50
Debt / FCF Ratio
-26.50-26.50-99.55-5.62-13.694.35
Net Debt / Equity Ratio
0.020.02-0.190.050.080.08
Net Debt / EBITDA Ratio
0.080.08-2.060.420.510.22
Net Debt / FCF Ratio
-1.48-1.4857.31-0.71-2.270.63
Asset Turnover
1.031.031.010.951.011.27
Inventory Turnover
4.934.934.254.024.224.32
Quick Ratio
3.113.113.182.312.572.38
Current Ratio
3.623.623.692.802.972.74
Return on Equity (ROE)
9.04%9.04%0.26%1.82%6.13%49.17%
Return on Assets (ROA)
6.43%6.43%0.08%1.31%3.83%29.40%
Return on Invested Capital (ROIC)
9.07%9.07%0.13%2.05%6.22%51.33%
Return on Capital Employed (ROCE)
9.73%9.73%-0.32%3.32%6.07%24.79%
Earnings Yield
6.28%2.90%-0.31%0.98%4.46%7.58%
FCF Yield
-7.67%-0.57%-0.22%-3.95%-2.57%2.59%
Buyback Yield / Dilution
1.08%1.08%0.81%-0.27%0.96%-20.03%
Total Shareholder Return
1.08%1.08%0.81%-0.27%0.96%-20.03%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q